Madam Chair, what I can say is this. Canada has not been a large player in biomanufacturing for a number of years. We have invested money to increase our capacity as a country, of course, to prepare for future health crises like this and because it is a valuable sector to have in Canada. I will say I am confident that the seven candidates we have procured are going to provide the diversity of vaccine candidates that will ensure that Canadians can get—
In the House of Commons on November 26th, 2020. See this statement in context.